We screened various anti-CD5 scFvs and selected the top four cells with high binding efficiency against CD5-expressing T cell leukemia cell line Jurkat (Supplementary Figure 1A) to obtain CD5 CAR-NK cells with enhanced efficacy against cells expressing the target antigen. This evidence concerns the gene CD5 and T-cell leukemia.